Bradley Foster & Sargent Inc. CT Trims Stock Position in Cigna Group $CI

Bradley Foster & Sargent Inc. CT cut its stake in Cigna Group (NYSE:CIFree Report) by 8.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,132 shares of the health services provider’s stock after selling 1,747 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Cigna Group were worth $4,837,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of CI. Assetmark Inc. lifted its position in Cigna Group by 10.0% during the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after buying an additional 5,963 shares during the period. apricus wealth LLC grew its position in shares of Cigna Group by 715.9% in the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Cigna Group by 3.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 105,534 shares of the health services provider’s stock worth $29,046,000 after buying an additional 3,814 shares during the period. OFI Invest Asset Management increased its stake in shares of Cigna Group by 8,357.8% in the 4th quarter. OFI Invest Asset Management now owns 33,070 shares of the health services provider’s stock worth $9,102,000 after acquiring an additional 32,679 shares in the last quarter. Finally, Polianta Ltd bought a new position in shares of Cigna Group in the 4th quarter worth about $1,568,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Trading Up 0.2%

Cigna Group stock opened at $290.06 on Monday. Cigna Group has a one year low of $239.51 and a one year high of $315.47. The business’s fifty day moving average is $286.05 and its 200 day moving average is $280.76. The stock has a market capitalization of $76.73 billion, a PE ratio of 12.30, a price-to-earnings-growth ratio of 1.12 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Wall Street Analyst Weigh In

CI has been the topic of several research reports. Wells Fargo & Company boosted their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Robert W. Baird set a $337.00 price target on Cigna Group in a research note on Friday, May 1st. Finally, Cantor Fitzgerald raised their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

View Our Latest Stock Report on CI

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.